BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 4256645)

  • 1. Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.
    Ogston D; Douglas AS
    Drugs; 1971; 1(3):228-46. PubMed ID: 4256645
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 3. The hematologic consequences of thrombolytic therapy.
    Fletcher AP; Alkjaersig NK
    Prog Hematol; 1986; 14():183-200. PubMed ID: 2935903
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
    Kwaan HC
    Thromb Diath Haemorrh Suppl; 1973; 56():239-51. PubMed ID: 4617331
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of platelet suppressant, anticoagulant and fibrinolytic therapy in patients with recurrent venous thrombosis.
    Steele P; Ellis J; Genton E
    Am J Med; 1978 Mar; 64(3):441-5. PubMed ID: 345802
    [No Abstract]   [Full Text] [Related]  

  • 7. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].
    Roĭtman EV; Dement'eva II; Meshcheriakov AV
    Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombelastographic patterns of ancrod and thrombin fibrin formation and dissolution.
    Caprini JA; Kwaan HC; Zuckerman L; Verduin R
    Thromb Res; 1974 Feb; 4(2):199-217. PubMed ID: 4275415
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biochemical basis for the control of anticoagulant and thrombolytic therapy].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):116-28. PubMed ID: 4098766
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
    Isacson S; Nilsson IM
    Scand J Haematol; 1970; 7(5):404-8. PubMed ID: 5486783
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinolytic agents.
    Sherry S
    Dis Mon; 1969 May; ():3-32. PubMed ID: 4241828
    [No Abstract]   [Full Text] [Related]  

  • 13. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current state of anticoagulant and fibrinolytic therapy].
    Hladovec J
    Cas Lek Cesk; 1971 Oct; 110(42):969-75. PubMed ID: 5114558
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of anticoagulants. Therapy and prophylaxis for thromboembolic phenomena.
    Quick D; Trowbridge AA
    Postgrad Med; 1984 Dec; 76(8):151-4, 156, 158-62. PubMed ID: 6504795
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulant treatment of venous thromboembolism.
    Coon WW
    Surg Annu; 1972; 4():151-63. PubMed ID: 4668856
    [No Abstract]   [Full Text] [Related]  

  • 17. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M
    Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864
    [No Abstract]   [Full Text] [Related]  

  • 18. [Various aspects of the effect of heparin-serotonin complex on blood and blood flow].
    Kondashevskaia MV; Sergeev VI; Liapina LA; Smolina TIu
    Izv Akad Nauk Ser Biol; 1998; (1):98-101. PubMed ID: 9542336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of thrombotic diseases.
    Douglas AS
    Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacology of platelet-inhibitory drugs, anticoagulants, and thrombolytic agents.
    Mehta JL; Kitchens CS
    Cardiovasc Clin; 1987; 18(1):163-79. PubMed ID: 3111692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.